Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients.

Jain D, Nayak NC, Saigal S.

Eur J Gastroenterol Hepatol. 2012 Jul;24(7):840-8. doi: 10.1097/MEG.0b013e3283534b40.

PMID:
22495397
2.

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.

Tokushige K, Hashimoto E, Horie Y, Taniai M, Higuchi S.

J Gastroenterol. 2011 Oct;46(10):1230-7. doi: 10.1007/s00535-011-0431-9. Epub 2011 Jul 13.

PMID:
21748549
3.

Obesity and hepatocellular carcinoma.

Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103. Review.

PMID:
15508109
4.

Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma.

Duan XY, Qiao L, Fan JG.

Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):18-27. Review.

5.

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.

Starley BQ, Calcagno CJ, Harrison SA.

Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594. Review.

PMID:
20432259
6.

Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.

Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH.

Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.

PMID:
20975341
7.

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

Nair S, Mason A, Eason J, Loss G, Perrillo RP.

Hepatology. 2002 Jul;36(1):150-5. Erratum in: Hepatology 2002 Sep;36(3):774.

PMID:
12085359
8.

Obesity and diabetes as a risk factor for hepatocellular carcinoma.

Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, Degos F, Farges O, Belghiti J.

Liver Transpl. 2004 Feb;10(2 Suppl 1):S69-73.

9.

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M.

Gastroenterology. 2002 Jul;123(1):134-40.

PMID:
12105842
10.

Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?

Guzman G, Brunt EM, Petrovic LM, Chejfec G, Layden TJ, Cotler SJ.

Arch Pathol Lab Med. 2008 Nov;132(11):1761-6. doi: 10.1043/1543-2165-132.11.1761.

PMID:
18976012
11.

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Baffy G, Brunt EM, Caldwell SH.

J Hepatol. 2012 Jun;56(6):1384-91. doi: 10.1016/j.jhep.2011.10.027. Epub 2012 Feb 9. Review.

12.

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

Kawamura Y, Arase Y, Ikeda K, Seko Y, Imai N, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ohmoto Y, Amakawa K, Tsuji H, Kumada H.

Am J Gastroenterol. 2012 Feb;107(2):253-61. doi: 10.1038/ajg.2011.327. Epub 2011 Oct 18.

PMID:
22008893
13.
14.

Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.

Tokushige K, Hashimoto E, Kodama K.

J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239. Review.

PMID:
24251711
15.

HCC and NASH: how strong is the clinical demonstration?

Rosmorduc O, Fartoux L.

Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):202-8. doi: 10.1016/j.clinre.2011.12.011. Epub 2012 Feb 10. Review.

PMID:
22326764
16.

Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.

Alexander J, Torbenson M, Wu TT, Yeh MM.

J Gastroenterol Hepatol. 2013 May;28(5):848-54. doi: 10.1111/jgh.12116.

PMID:
23302015
17.

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.

El-Serag HB, Richardson PA, Everhart JE.

Am J Gastroenterol. 2001 Aug;96(8):2462-7.

PMID:
11513191
18.

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.

Beale G, Chattopadhyay D, Gray J, Stewart S, Hudson M, Day C, Trerotoli P, Giannelli G, Manas D, Reeves H.

BMC Cancer. 2008 Jul 18;8:200. doi: 10.1186/1471-2407-8-200.

19.

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K.

J Gastroenterol Hepatol. 2009 Feb;24(2):248-54. doi: 10.1111/j.1440-1746.2008.05640.x. Epub 2008 Nov 20.

PMID:
19032450
20.

[Two cases of patients with hepatocellular carcinoma (HCC) that developed in cryptogenic cirrhosis suggestive of nonalcoholic steatohepatitis (NASH) as background liver disease after clinical courses of 26 years].

Tsutsumi K, Nakayama H, Sakai Y, Kojima Y, Dairaku N, Ojima T, Kusano M, Ikeya S, Sugai Y, Hiwatashi N.

Nihon Shokakibyo Gakkai Zasshi. 2007 May;104(5):690-7. Japanese.

PMID:
17485950

Supplemental Content

Support Center